SCHEMBL5173995

SCHEMBL5173995

NC(=O)c1ccccc1C[CH]c1nc2ccccc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.44
NPC1 O15118 5/20 0.44
PARP1 P09874 3/20 0.43
CYP3A4 P08684 1/20 0.43
KDM4E B2RXH2 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 3/20 0.41
PKM P14618 2/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSP90AA1 P07900 1/20 0.41
LMNA P02545 3/20 0.40
TRPV1 Q8NER1 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39
CHRM1 P11229 1/20 0.39
MAPK10 P53779 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2982645 0.80 FAAH (0.47) RAB9ANPC1PARP1CYP3A4KDM4E
SCHEMBL7080316 0.77 GAA (0.53) RAB9ANPC1KDM4EALDH1A1PKM
SCHEMBL4236214 0.77 CYP3A4 (0.56) RAB9ANPC1CYP3A4MEN1KMT2A
SCHEMBL4802582 0.74 MAPK1 (0.50) PARP1KDM4EKMT2AALDH1A1SMN1; SMN2
SCHEMBL5171595 0.74 BRD4 (0.44) PARP1KDM4EALDH1A1HPGD
SCHEMBL5117216 0.74 CYP3A4 (0.54) RAB9ANPC1CYP3A4KDM4EMEN1
SCHEMBL6785579 0.73 KDM4E (0.34) PARP1KDM4EMEN1KMT2AALDH1A1
SCHEMBL630977 0.73 PARP1 (0.56) PARP1
SCHEMBL5627161 0.72 RAB9A (0.56) RAB9ANPC1KDM4EMEN1KMT2A
SCHEMBL4101513 0.70 KDM4E (0.47) RAB9ANPC1PARP1CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP claimed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO claimed
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed